Two Newfoundland bioscience companies latest to join Emergence Incubator

July 11, 2023

Nucliq Biologics and Polyamyna Nanotech are the two latest companies to join Emergence, Atlantic Canada’s bioscience business incubator which is dedicated to assisting start-ups and growth-stage companies in the commercialization of bioscience-based technologies and services. These two companies are headquartered in Newfoundland, demonstrating the strength and viability of the sector in the province.  

“We are pleased to welcome Nucliq Biologics and Polyamyna Nanotech to Emergence,” said Jason Cleaversmith, Director of Incubation, PEI BioAlliance. “Each of these companies have unique strengths and are making important discoveries that will enhance healthcare in years to come.”

Nucliq Biologics

At Nucliq Biologics, they are on a mission to uncover your gut microbiome. Co-founded by Dr. Nikitha Kendyala and Dr. Purvikalyan Pallegar in 2019, Nucliq Biologics is pioneering the standard of preventative health care, with an unwavering commitment to microbiome research. After years of research and learning about the microbiome, the founders were startled with how society ignored our microbiome and its massive potential for human well-being. Nucliq Biologics is on a mission to help you embrace a healthier future by unlocking the hidden potential of your microbiome.

“We are thrilled to announce our partnership with Emergence. With great access to invaluable mentorship, resources, and a vibrant network of like-minded bioscience pioneers, we are positioned to accelerate our growth across Atlantic Canada and beyond,” said Purvikalyan Pallegar, Co-founder and CTO, Nucliq Biologics. “We’re excited to join a collaborative ecosystem working towards a shared vision of shaping a bright future for bioscience in Atlantic Canada. We are eager to leverage this opportunity to make a lasting impact on the health and well-being of individuals across the country.”

Learn more about Nucliq Biologics at:

Polyamyna Nanotech

Polyamyna has developed next generation, highly effective and durable antimicrobial technologies to prevent infections caused by the deadly ESKAPE pathogens. Their mission is to support infection control practices and reduce the impact of healthcare associated infections by significantly enhancing surface cleanliness. 

“We are grateful for the association with the Emergence team as it will undoubtedly strengthen our knowledge and help us to gain further insights on supporting the growth of our company,” said Bala Gorityala, Co-Founder and CTO, Polyamyna Nanotech.

Learn more about Polyamyna Nanotech at

Emergence provides companies with business incubation services including the Critical Path program, one-on-one and team mentorship, business strategy and advisory services, as well as access to the Emergence Performance Network. Emergence Advisor Matt Roberts is located in Newfoundland, supporting companies with financial guidance and analysis, investor-readiness, and connecting to investor networks. Emergence is also working closely with Bounce Innovation in Newfoundland to identify companies that are a good fit with the Emergence Incubator.